These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15598470)

  • 1. Multidrug resistance in yeast Candida.
    Prasad R; Kapoor K
    Int Rev Cytol; 2005; 242():215-48. PubMed ID: 15598470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
    Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
    Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of multidrug resistance in pathogenic fungi.
    Morschhäuser J
    Fungal Genet Biol; 2010 Feb; 47(2):94-106. PubMed ID: 19665571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
    FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
    Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
    Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to azole antifungals.
    Marichal P; Vanden Bossche H
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2.
    Bruno VM; Mitchell AP
    Mol Microbiol; 2005 Apr; 56(2):559-73. PubMed ID: 15813744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole susceptibility and resistance in Candida dubliniensis.
    Pinjon E; Moran GP; Coleman DC; Sullivan DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
    Cernicka J; Subik J
    Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug transporters of Candida species in clinical azole resistance.
    Prasad R; Nair R; Banerjee A
    Fungal Genet Biol; 2019 Nov; 132():103252. PubMed ID: 31302289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opportunistic pathogen Candida glabrata and the mechanisms of its resistance to antifungal drugs].
    Berila N; Subík J
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):67-79. PubMed ID: 20586168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of antifungal resistance.
    Vanden Bossche H
    Rev Iberoam Micol; 1997 Jun; 14(2):44-9. PubMed ID: 16854169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MFS transporters of Candida species and their role in clinical drug resistance.
    K Redhu A; Shah AH; Prasad R
    FEMS Yeast Res; 2016 Jun; 16(4):. PubMed ID: 27188885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.